FINANCIAL PERFORMANCE ANALYSIS
Revenue Metrics:
• Annual Collections: $1,300,000+ (2025 projected)
• Cash Revenue Composition: 60% ($780,000+ cash-based services)
• Insurance Revenue: 40% ($520,000+ diversified payor mix)
• Patient Base: 7,000+ active patients (3-year period)
• Daily New Patient Inquiries: 12-17 (demand exceeding capacity)
OPERATIONAL EFFICIENCY INDICATORS
Capacity Utilization:
• Current Status: 100% capacity with waitlist
• Facility: 1,600 SF medical space (optimal space-to-revenue ratio)
• Clinical Infrastructure: 5 exam rooms + procedure suite + lab + ultrasound
• Staffing Model: 2 experienced Nurse Practitioners + stable support team
Market Position:
• Market Tenure: 17+ years established presence
• Geographic Advantage: Affluent Southeastern metro suburb
• Specialty Focus: GYN-only practice (reduced competition)
• Referral Network: Multi-state patient draw established
REVENUE DIVERSIFICATION ANALYSIS
High-Margin Service Lines:
• Hormone Therapy (cash-based)
• Weight Management Programs (cash-based)
• Aesthetic Services (cash-based)
• Traditional GYN Services (insurance reimbursed)
Risk Mitigation Factors:
• 60% cash revenue reduces reimbursement dependency
• Diversified payor mix minimizes single-source risk
• Established patient loyalty (17-year track record)
• Essential healthcare services (recession-resistant)
GROWTH SCALABILITY METRICS
Immediate Expansion Opportunities:
• Patient Capacity: Currently waitlisted (immediate revenue potential)
• Provider Addition: Infrastructure supports additional clinicians
• Service Expansion: Pelvic floor therapy, wellness memberships
• Digital Marketing: Untapped potential for cash-service growth
QUANTIFIABLE ADVANTAGES
• Patient Retention: 7,000+ active patients demonstrate loyalty
• Demand Validation: 12-17 daily inquiries confirm market strength
• Cash Flow Stability: 60% cash revenue provides predictable income
• Operational Leverage: Capacity constraints indicate pricing power
TRANSITION STRUCTURE
Owner transitioning to semi-retirement with structured handoff support including clinical consultation to ensure revenue continuity and growth trajectory maintenance.
DUE DILIGENCE PACKAGE
Comprehensive Confidential Business Review is available to qualified buyers under NDA.
Ad#:2355317
